Live investor webinar hosted by David Regan, CEO and Len Pagliaro PhD, CSO in which they discuss the development of Sona’s pre-clinical Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.
Live investor webinar hosted by David Regan, CEO and Len Pagliaro PhD, CSO in which they discuss the development of Sona’s pre-clinical Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.